News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biomarker Technologies LLC To Begin Pilot Study Of A New Blood Test For Breast Cancer


10/19/2005 5:13:06 PM

PHOENIX--(BUSINESS WIRE)--March 23, 2005-- BT Test(TM) Provides Early Detection, Cost Effective Diagnostic Blood Test Biomarker Technologies LLC, the worldwide technology provider of the blood diagnostic test for the detection of breast cancer called the BT Test(TM), announced today plans to begin a pilot study of the test in the United States beginning in April 2005. The company is conducting the pilot study to verify its prior results and make final preparations for FDA clinical studies. The study will be a retrospective blind test with samples from healthy participants, those with untreated breast cancer, as well as those from a select group of other cancer conditions in order to demonstrate the differentiation capabilities of the test. In initial studies involving more than 250 subjects, the BT Test successfully identified non-treated breast cancer in women with a greater than 95% sensitivity and specificity, outperforming mammography.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES